المؤلفون: Larkin J., Weber J., Del Vecchio M., Gogas H., Arance A. M., Dalle S., Cowey C. L., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez-Rodas I., Butler M. O., Di Giacomo A. M., Middleton M. R., De la Cruz-Merino L., Arenberger P., Atkinson V., Hill A., Fecher L. A., Millward M., Khushalani N. I., Queirolo P., Long G. V., Lobo M., Askelson M., Ascierto P. A., Mandala M.

المساهمون: Larkin, J., Weber, J., Del Vecchio, M., Gogas, H., Arance, A. M., Dalle, S., Cowey, C. L., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez-Rodas, I., Butler, M. O., Di Giacomo, A. M., Middleton, M. R., De la Cruz-Merino, L., Arenberger, P., Atkinson, V., Hill, A., Fecher, L. A., Millward, M., Khushalani, N. I., Queirolo, P., Long, G. V., Lobo, M., Askelson, M., Ascierto, P. A., Mandala, M.

مصطلحات موضوعية: AJCC-8 criteria, Distant metastase, Ipilimumab, Melanoma adjuvant therapy, Nivolumab, Recurrence-free survival, Stage 3, Adjuvants, Immunologic, Human, Neoplasm Staging, Melanoma, Skin Neoplasms

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35964471; info:eu-repo/semantics/altIdentifier/wos/WOS:000922633300002; volume:173; firstpage:285; lastpage:296; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11365/1221042Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85135858543; https://www.sciencedirect.com/science/article/pii/S0959804922003926Test

الإتاحة: https://doi.org/10.1016/j.ejca.2022.06.041Test
https://hdl.handle.net/11365/1221042Test
https://www.sciencedirect.com/science/article/pii/S0959804922003926Test

المؤلفون: Ascierto, PA, Dréno, B, Larkin, J, Ribas, A, Liszkay, G, Maio, M, Mandalà, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Atkinson, V, Dutriaux, C, Garbe, C, Hsu, J, Jones, S, Li, H, McKenna, E, Voulgari, A, McArthur, GA

المساهمون: Larkin, James

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Azetidines, Follow-Up Studies, Humans, Melanoma, Mutation, Piperidines, Proto-Oncogene Proteins B-raf, Skin Neoplasms, Vemurafenib

جغرافية الموضوع: United States

وصف الملف: Print; 5235; application/pdf

العلاقة: 1078-0432.CCR-21-0809; Clinical Cancer Research, 2021, 27 (19), pp. 5225 - 5235; https://repository.icr.ac.uk/handle/internal/5284Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-0809Test
https://repository.icr.ac.uk/handle/internal/5284Test

المؤلفون: Mandala, M, Larkin, J, Ascierto, PA, Del Vecchio, M, Gogas, H, Cowey, CL, Arance, A, Dalle, S, Schenker, M, Grob, J-J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, MO, Di Giacomo, AM, Lutzky, J, De La Cruz-Merino, L, Atkinson, V, Arenberger, P, Hill, A, Fecher, L, Millward, M, Khushalani, NI, de Pril, V, Lobo, M, Weber, J

المساهمون: Larkin, James

مصطلحات موضوعية: adjuvants, immunologic, immunotherapy, melanoma, programmed cell death 1 receptor, Aged, Disease-Free Survival, Female, Humans, Immune Checkpoint Inhibitors, Neoplasm Staging, Nivolumab, Treatment Outcome

جغرافية الموضوع: England

وصف الملف: Print; application/pdf

العلاقة: ARTN e003188; jitc-2021-003188; Journal for ImmunoTherapy of Cancer, 2021, 9 (8), pp. e003188 -; https://repository.icr.ac.uk/handle/internal/5285Test

الإتاحة: https://doi.org/10.1136/jitc-2021-003188Test
https://repository.icr.ac.uk/handle/internal/5285Test

المؤلفون: Dréno, B, Ascierto, PA, Atkinson, V, Liszkay, G, Maio, M, Mandalà, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Dutriaux, C, Garbe, C, Bartley, K, Karagiannis, T, Chang, I, Rooney, I, Koralek, DO, Larkin, J, McArthur, GA, Ribas, A

المساهمون: Larkin, James

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Azetidines, Double-Blind Method, Female, Humans, Longitudinal Studies, Male, Melanoma, Mutation, Piperidines, Placebos, Proto-Oncogene Proteins B-raf, Quality of Life, Vemurafenib

جغرافية الموضوع: England

وصف الملف: Print-Electronic; 784; application/pdf

العلاقة: bjc2017488; British Journal of Cancer, 2018, 118 (6), pp. 777 - 784; https://repository.icr.ac.uk/handle/internal/5296Test

الإتاحة: https://doi.org/10.1038/bjc.2017.488Test
https://repository.icr.ac.uk/handle/internal/5296Test

المؤلفون: Mandala M., Larkin J., Ascierto P. A., Del Vecchio M., Gogas H., Cowey C. L., Arance A., Dalle S., Schenker M., Grob J. -J., Chiarion-Sileni V., Marquez I., Butler M. O., Di Giacomo A. M., Lutzky J., De La Cruz-Merino L., Atkinson V., Arenberger P., Hill A., Fecher L., Millward M., Khushalani N. I., De Pril V., Lobo M., Weber J.

المساهمون: Mandala, M., Larkin, J., Ascierto, P. A., Del Vecchio, M., Gogas, H., Cowey, C. L., Arance, A., Dalle, S., Schenker, M., Grob, J. -J., Chiarion-Sileni, V., Marquez, I., Butler, M. O., Di Giacomo, A. M., Lutzky, J., De La Cruz-Merino, L., Atkinson, V., Arenberger, P., Hill, A., Fecher, L., Millward, M., Khushalani, N. I., De Pril, V., Lobo, M., Weber, J.

مصطلحات موضوعية: adjuvant, immunologic, immunotherapy, melanoma, programmed cell death 1 receptor

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34452930; info:eu-repo/semantics/altIdentifier/wos/WOS:000691920700003; volume:9; issue:8; firstpage:1; lastpage:9; numberofpages:9; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; https://hdl.handle.net/11365/1233242Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114247620; https://jitc.bmj.com/content/9/8/e003188Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404438Test/

الإتاحة: https://doi.org/10.1136/jitc-2021-003188Test
https://hdl.handle.net/11365/1233242Test
https://jitc.bmj.com/content/9/8/e003188Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404438Test/

المؤلفون: Majem, M, Manzano, J L, Marquez-Rodas, I, Mujika, K, Muñoz-Couselo, E, Pérez-Ruiz, E, de la Cruz-Merino, L, Espinosa, E, Gonzalez-Cao, M, Berrocal, A

مصطلحات موضوعية: Adjuvant treatment metastatic treatment, Melanoma, Staging, Biopsy, Brain Neoplasms, Chemotherapy, Adjuvant, Follow-Up Studies, Humans, Immunotherapy, Lymph Node Excision, Medical Oncology, Molecular Targeted Therapy, Neoplasm Staging, Proto-Oncogene Proteins B-raf, Radiotherapy, Skin Neoplasms, Societies, Medical, Spain

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/17259Test; PMC8057998; https://link.springer.com/content/pdf/10.1007/s12094-020-02539-9.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057998/pdfTest

الإتاحة: https://doi.org/10.1007/s12094-020-02539-9Test
http://hdl.handle.net/10668/17259Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057998/pdfTest

المؤلفون: Dreno B., Ascierto P. A., Atkinson V., Liszkay G., Maio M., Mandala M., Demidov L., Stroyakovskiy D., Thomas L., De La Cruz-Merino L., Dutriaux C., Garbe C., Bartley K., Karagiannis T., Chang I., Rooney I., Koralek D. O., Larkin J., McArthur G. A., Ribas A.

المساهمون: Dreno, B., Ascierto, P. A., Atkinson, V., Liszkay, G., Maio, M., Mandala, M., Demidov, L., Stroyakovskiy, D., Thomas, L., De La Cruz-Merino, L., Dutriaux, C., Garbe, C., Bartley, K., Karagiannis, T., Chang, I., Rooney, I., Koralek, D. O., Larkin, J., Mcarthur, G. A., Ribas, A.

مصطلحات موضوعية: BRAF inhibitor, Cobimetinib, EORTC QLQ-C30, HRQOL, MEK inhibitor, Metastatic melanoma, Vemurafenib, Antineoplastic Combined Chemotherapy Protocol, Azetidine, Double-Blind Method, Female, Human, Longitudinal Studie, Male, Melanoma, Piperidine, Placebo, Proto-Oncogene Proteins B-raf, Quality of Life, Mutation

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29438370; info:eu-repo/semantics/altIdentifier/wos/WOS:000427945800016; volume:118; issue:6; firstpage:777; lastpage:784; numberofpages:8; journal:BRITISH JOURNAL OF CANCER; http://hdl.handle.net/11365/1083773Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85044192869; http://www.nature.com/bjc/index.htmlTest

الإتاحة: https://doi.org/10.1038/bjc.2017.488Test
http://hdl.handle.net/11365/1083773Test
http://www.nature.com/bjc/index.htmlTest

المؤلفون: Weber, Jeffrey S., Schadendorf, Dirk, Ascierto, Paolo A., Sandhu, Shahneen, Eigentler, Thomas, Gutzmer, Ralf, Hassel, Jessica C., Robert, Caroline, Carlino, Matteo S., Di Giacomo, Anna Maria, Butler, Marcus O., Muñoz-Couselo, Eva, Del Vecchio, Michele, Brown, Michael P., Rutkowski, P, Haydon, A, Grob, J-J, Schachter, J, Queirolo, P, de la Cruz-Merino, L, van der Westhuizen, Andre, Menzies, AM, Re, S, Larkin, James, Bas, T, de Pril, V, Braverman, J, Tenney, DJ, Tang, H, Long, GV, Atkinson, Victoria, Schenker, Michael, Pigozzo, Jacopo, Gogas, Helen, Dalle, Stéphane, Meyer, Nicolas

المساهمون: The University of Newcastle. College of Health, Medicine & Wellbeing, School of Medicine and Public Health

مصطلحات موضوعية: melanoma, patients, nivolumab, treatment, SDG 3, Sustainable Development Goals

العلاقة: Journal of Clinical Oncology Vol. 41, Issue 3, p. 517-527; http://hdl.handle.net/1959.13/1480886Test; uon:50584

الإتاحة: http://hdl.handle.net/1959.13/1480886Test

المؤلفون: Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J. -J., Nathan, P., Dummer, R., Forsea, A. -M., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., Rutkowski, P., Krajsova, I., Bylaite-Bucinskiene, M., Zalaudek, I., Maric-Brozic, J., Babovic, N., Banjin, M., Putnik, K., Weinlich, G., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Kukushkina, M., De La Cruz Merino, L., Ymeri, A., Risteski, M., Garbe, C.

المساهمون: Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J. -J., Nathan, P., Dummer, R., Forsea, A. -M., Hoeller, C., Gogas, H., Demidov, L., Lebbe, C., Blank, C., Olah, J., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Hansson, J., Rutkowski, P., Krajsova, I., Bylaite-Bucinskiene, M., Zalaudek, I., Maric-Brozic, J., Babovic, N., Banjin, M., Putnik, K., Weinlich, G., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Kukushkina, M., De La Cruz Merino, L., Ymeri, A., Risteski, M., Garbe, C.

مصطلحات موضوعية: Acce, Health expenditure per capita, Human development index, Immunooncology, Innovative medicine, Metastatic melanoma, Targeted therapy, Treatment, Acrylonitrile, Aniline Compound, Antibodies, Monoclonal, Humanized, Europe, Female, Health Services Accessibility, Healthcare Disparitie, Human, Immunotherapy, Male, Melanoma, Programmed Cell Death 1 Receptor, Proto-Oncogene Proteins B-raf, Reimbursement Mechanism, Skin Neoplasm, Therapies, Investigational, Oncology, Cancer Research

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28264791; info:eu-repo/semantics/altIdentifier/wos/WOS:000399856400040; volume:75; firstpage:313; lastpage:322; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11368/2923064Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85014383793; http://www.ejcancer.com/article/S0959-8049Test(17)30069-2/abstract

الإتاحة: https://doi.org/10.1016/j.ejca.2017.01.012Test
http://hdl.handle.net/11368/2923064Test
http://www.ejcancer.com/article/S0959-8049Test(17)30069-2/abstract

المؤلفون: de la Cruz-Merino, L, Di Guardo, L, Grob, J-J, Venosa, A, Larkin, J, McArthur, GA, Ribas, A, Ascierto, PA, Evans, JTR, Gomez-Escobar, A, Barteselli, G, Eng, S, Hsu, JJ, Uyei, A, Dréno, B

المساهمون: Larkin, James, Marsden

مصطلحات موضوعية: Humans, Melanoma, Skin Neoplasms, Recurrence, Sulfonamides, Azetidines, Piperidines, Indoles, Proto-Oncogene Proteins B-raf, Mutation, Time Factors, Adult, Aged, Middle Aged, Female, Male, Central Serous Chorioretinopathy, Vemurafenib

وصف الملف: Electronic; ?; image/png

العلاقة: Journal of translational medicine, 2017, 15 (1), pp. 146 - ?; https://repository.icr.ac.uk/handle/internal/1256Test

الإتاحة: https://doi.org/10.1186/s12967-017-1246-0Test
https://repository.icr.ac.uk/handle/internal/1256Test